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The response to treatment was about 20%
higher in the clinical trial group. The 20%
difference between the outcomes in the
prospective and retrospective studies recorded
in the response to treatment was similar in the 1,
2, and 3 years local controi observations.
62.
THE RADIOTHERAPY OF IMRT
S.M. Bentzen
Gray Institute of Cancer Research, Mount
Vernon Hospital, Northwood, Middlesex, UK
Intensity Modulated Radiotherapy (IMRT) is
going to revolutionise treatment planning and
delivery of radiotherapy in the next few years.
Although there are still technological constraints,
IMRT allows delivery of a specified dose-
distribution that is superior to what is realistically
achievable with 3D conformal radiotherapy
using standard techniques. This forces a re-
think of the whole process of delivering
radiotherapy. With our current technology, the
physics has overtaken the biology and it
appears that to realise the fuli potential of IMRT,
a major research effort on the biological aspects
of radiotherapy is needed. This goes far beyond
traditional cellular radiobiology. New powerful
assays in molecular biology and bioimaging will
be key elements in the biological optimisation of
radiotherapy. In this lecture, I will try to identify
some of the research areas that will need to be
further developed in order to get the fuli
therapeutic benefit from IMRT.
63.
STEREOTACTIC RADIOTHERAPY
FOR PRIMARY AND RECURRENT
BRAIN TUMORS. A NEW METHOD
FOR IMPROVEMENT OF THE
TREATMENT RESUlTS?
J. Fijuth
Centrum Onkologii - Instytut, Warszawa
To evaluate the effectiveness of the
stereotactic radiosurgery (SRS) and stereotactic
fractionated radiotherapy in the primary,
recurrent and metastatic brain tumors.
To present potential usefulness of stereotactic
boost in anaplastic astrocytomas (AA) and
glioblastoma multiforme (GBM).
56
Between March 2000 and December 2000,
SRS was applied in 23 patients (pts) with brain
tumors (metastatic tumors - 9 pts, recurrent
tumors - 7 pts, primary meningiomas - 4 pts,
vascular malformations - 3 pts).
Fractionated stereotactic radiotherapy was
applied in 6 pts (recurrent anaplastic gliomas - 2
pts, recurrent medulloblastoma - 1 pt, acustic
neurinoma - 1 pt, meningioma - 1, pituitary
adenoma - 1).
Detailed technique of treatment planning is
presented and discussed. The planning target
volume (PTV) and organs at risk (OAR) were
assessed comparing dose statistics, dose
volume histograms and RTOG stereotactic
radiosurgery criteria.
Recommendations regarding the total dose
level and fractional dose are proposed.
The treatment tolerance and preliminary results
are presented.
The own protocol of stereotactic boost to
residual tumor using SRS after initial conformal
radiotherapy in patients with AA and GBM is
presented and discussed.
64.
STATE OF MONTE CARLO
CAlCUlATIONS IN RADlATlON
TREATMENT PlANNING
U. Rosenow
Instytut: Georg-August-Universitat Gottingen
Department for Clinical Radiation Biology and
Clinical Radiation Physics Gottingen
Monte Carlo (MC) particie transport
simulations are increasingly applied in treatment
planning methods. This has become feasible
through a number of adaptations of general MC
codes, such as EGS4 ar ETRAN, to the specific
needs of treatment planning. The currently most
advanced "conventional" planning methods,
such as convolution or delta-volume algorithms
still have serious limitations in terms of accuracy
when tissue inhomogeneities, smali and
complex body shapes or high-density implants
are involved. The Monte Carlo simulation
mimics individual particie transport, in any
applicable geometry, by applying first principles
of radiation interaction with matter and random
choice of collision parameters such as step
length, type of interaction, energies and
scattering angles. In principle, the accuracy of
MC calculations is only Iimited the radiation
beam quality definition and the interaction
parameters and can be taken to below 12%. In
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practice, a very large number ot particie
"histories" have to be simulated to attain
sufficient statistical accuracy, and various
approximations (e. g. condensed history,
variance reduction) have been introduced in the
process ot adaptation of MC codes to the
special needs ot treatment planning. Such
codes have become known as V(oxel)MC and
X(ray)VMC, M(acro)MC, S(uper)MC,
MCPAT(ient...). These will be described in detail
and performance characteristics as well as
treatment planning examples given. While the
general-purpose MC codes result in computing
times per case ot the order ot several hours, the
special treatment planning codes reduce this
time to around an hour or even much less on
modern workstations or Pentium-based PCs.
65.
PHYSICAL AND CLlNICAL
DOSIMETRY BY MEANS OF MONTE
CARLO USING A PROCESS
DISTRIBUTION TOOl
F. Sanchez-Doblado, A. Leal, M. Perucha,
M. Rincon, L. Nunez, J. Rosello,A. Gonzalez,
E. Carrasco, J.C. Medrano,
J.A. Sanchez-Calzado, L. Errazquin
Universidad de Sevilla and Hospital Univ. Virgen
Macarena de Sevilla, Hospital Univ. Virgen
Macarena de Sevilla, Clinica Puerta de Hierro,
Madrid, Hospital General (ERESA), Valencia
The choice ot the most appropriate strategy in
a Radiotherapy treatment is mainly based on the
use ot a planning system. With the introduction
ot new techniques (contormal and/or smali
tields, asymmetrical and non coplanar beams,
true 3D calculations, IMRT) the trustworthiness
ot the algorithms is being questioned. An
alternative verification procedure is every time
more neeessary to warranty a treatment
delivery. The reliability ot Monte Carlo is
generally accepted. However, its elinieal use has
not been operative due to the high CPU times
needed. During the last tew years our objeetive
has been focussed to reduee this time by means
ot new process distribution techniques. Tnis
drop has made it teasible, not only the physical
dosimetry under special eonditions, but ałso a
numerous variety ot elinical cases: photon and
eleetron eontormai tields, Radiosurgery and
IMRT. The carried out procedure is presented.
Furthermore, experimental dosimetry data as
well as conventional TPS calculations are
compared with Monte Carlo simulations.
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66.
LATE EFFECTS OF CNS PROPHY-
LACTIC IRRADIATION IN CHILD-
HOOD DUE TO LLA USING
MAGNETIC RESONANCE SPECTRO-
SKOPY. (PRELIMINARY REPORT)
K. Ficek, R. Tarnawski, L. Miszczyk, S. Blamek
Department of Radiotherapy - Center of
Oneology, Gliwice.
Purpose: The aim of this study was to
evaluate changes in magnetic resonance
imaging (MRI) and magnetic resonance
spectroscopy (MRS) ot the brain in survivars
with Aeute Lymphoblastic Leukemia to assess
neurotixieity tollow protilactic brain irradiation.
Methods: Ten trom 100 patients with LLA
treated in Department of Pediatrie Hematology
trom 1990 to 1995 and irradiated in Centre ot
Oneology were icluded in MRI and MRS studies.
The study group ineluded 6 małe and 4 temale.
Ali patients had been irradiated tor brain using
traction dose ot 1,8 Gy up to total dose ot 18 Gy
and had reeived MTX based ehemotherapy in
doses depending on level ot risk. Two ot them
were ineluded in low risk and eight in
intermediate risk.
Results: MRI ot brain was abnormal in 5
cases. There were mild white matter changes.
The changes were Been in H- MRS metabolite
ratios. In one of these cases we observed a
impair ot verbal tunctions.
Conclusions: The MRS could be valuable
method to access brain tissue metabolism after
radiotherapy. That noninvasive method may be
recomended for children with LLA to observe
neurotoxicity ot protilactie irradiation.
67.
RADICAL RADIOTHERAPY OF
MUSCLE-INVADING BLADDER
CANCER (BC): ARETROSPECTIVE
ANALYSIS OF 49 PATIENTS
R. Zaucha, A. Kobierska, M. Nowaczyk,
J. Zaborowska, J. Jassem
Med. Univ.ot Gdansk, Woj. Przych. Onkolog.
w Gdansku, Por. Onk. w Koscierzynie
Growing interest in the use ot combined
modality approaches tor bladder-sparing
procedures force radiation oncologists to
optimise methods ot radical radiotherapy. Since
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